Merkel cell carcinoma: a review

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer.
• Its etiology is largely unknown but associated with a specific polyomavirus.
• The elderly population is predominantly affected.

Purpose of the Study:

• To provide a comprehensive review of Merkel cell carcinoma.
• To discuss the historical context, pathogenesis, and clinical presentation of MCC.
• To outline current and potential future treatment strategies.

Main Methods:

• Literature review of historical data, epidemiological studies, and clinical trials.
• Analysis of the role of polyomavirus in MCC pathogenesis.
• Synthesis of information on immune response in MCC development and treatment.

Main Results:

• A novel polyomavirus is identified in a significant proportion of MCC cases.
• Immune response is a critical factor in MCC pathogenesis and progression.
• Current treatment modalities include surgery, radiation, and chemotherapy, with immunotherapy emerging.

Conclusions:

• MCC is a complex malignancy with viral and immune underpinnings.
• Understanding pathogenesis is key to developing effective therapies.
• Future research should focus on targeted immunotherapies and novel treatment combinations.